April 17 CASMED Announces FDA Approval of Next Generation FORE-SIGHT Absolute Tissue Oximeter

[at noodls] – CASMED Announces FDA Approval of Next Generation FORE-SIGHT Absolute Tissue Oximeter Branford, Conn. (April 17, 2013) – CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for … more

View todays social media effects on CASM

View the latest stocks trending across Twitter. Click to view dashboard

See who CAS is hiring next, click here to view